본문 바로가기
사이트 내 전체검색

보건직
연구
보건직

RPRD | Facile synthesis of 6-[18F]FDOPA using electrophilic substitution reac…

페이지 정보

작성자 : 서울대 핵의학과 작성일2017-02-02 조회3,023회

본문

Yong-Hyun Cho2, Yun-Sang Lee1, Jae Hyung Lee2, Yong-Seok Lee2, Hong-Jae Lee2, Jin-Eui Kim2, Keon-Wook Kang1, Jae Min Jeong1*

1Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea

2Nuclear Medicine, Seoul National University Hospital, Seoul, Korea

 

 

Purpose

 

[18F]FDOPA has been synthesized using CFCl3 as a solvent for electrophilic substitution reaction because of high yield and convenience. However, many laboratories replaced CFCl3 with other solvents such as CHCl3, CDCl3, CH2Cl2, or CD2Cl2 since the effect of Montreal Protocol [1-3]. We tried to set up a procedure for the most simple and high yield using CDCl3 as a solvent.

 

 

Materials and Methods

 

We used an automated synthesizer Fx-Fn (GE, U.S.A.) for production. [18F]F2 gas was produced by 20Ne(d,α)18F reaction in the presence of 0.1% F2 gas using a cyclotron and was passed through the reaction vial containing 30 mg precursor in 1 mL CDCl3 at room temperature. After purging for 10 min, solvent was evaporated by raising temperature to 130 °C and further 30 sec purging. Hydrolysis was performed using 0.6 mL HBr (48%) at 130°C for 10 min. The reaction mixture was neutralized with 0.6 mL NH4OH (28%), and then was injected into the HPLC equipped with a semi-prep reverse phase column (Fig. 1).

 

 

Results

 

Synthesis time including purification was less than 35 min and final yield was 19.3 ± 3.1% (no decay corrected). Specific activity was 20.2 ± 4.6 GBq/ mmol. HPLC eluent was in 0.5% acetic acid. We added 0.5 mL 8.6% NaHCO3 to neutralize it before injection into the patients. [18F]FDOPA was stable for at least 2 h at room temperature.

 

 

Conclusion

 

We successfully developed a high yield, simple and fast electrophilic synthesis method for [18F]FDOPA.

 



서울특별시 종로구 대학로 101 (연건동 28)
진료예약안내 | 1588-5700
Copyrightⓒ 2017 Department of Nuclear Medicine Seoul National University Hospital. All Rights Reserved.
환자권리장전
서울대학교병원은 환자중심,인간존중,지식창조,사회봉사라는 경영이념을 통해 신체적/정신적 어려움으로 병원을 찾는 모든 환자의 권리를 존중하고, 최선의 진료를 제공하기 위하여 다음과 같이 선언한다.
존엄의 권리
환자는 존엄한 인간으로서 예우받을 권리가 있다.
평등의 권리
환자는 성별, 연령, 종교 또는 사회적 신분을 떠나 평등한 진료를 받을 권리가 있다.
설명을 들을 권리
환자는 의료진으로부터 질병의 진단,치료계획,결과,예후에 대한 설명을 들을 권리가 있다.
선택의 권리
환자는 치료,검사,수술,입원 등 본인에게 이루어지는 의료행위에 대한 설명을 듣고 시행여부를 선택할 권리가 있다.
개인신상 비밀을 보호받을 권리
환자는 진료내용,신체의 비밀 및 개인생활의 비밀을 보호받을 권리가 있다.